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Sub-Saharan Africa accounts for 69% of the global HIV burden. Due to a variety of social,
economic and behavioural factors, mentally ill patients are more likely to engage in high risk
sexual behaviours. In turn, co-morbid substance use which is present in up to 75% of 
mentally ill patients is a leading risk factor for sexual risk behaviours. Worldwide 
methamphetamines are the most commonly used illicit stimulant. Both injectable and non-
injectable methamphetamines have evidenced associations with high risk sexual behaviours.
Smoking and inhalation of crystal methamphetamine is the predominant mode of use in
South Africa. The use of crystal methamphetamine amongst mentally ill persons in Cape
Town has escalated over the last decade. We aimed to determine the occurrence of 
methamphetamine use and risky sexual practices amongst mentally ill patients. In addition 
we aimed to explore the associations between methamphetamine use and HIV sexual risk
behaviours in a sample of mentally ill inpatients in Cape Town, South Africa.
Methodology 
A total of 100 participants were recruited between July 2010 and March 2012, from the adult
in-patient population at a psychiatric hospital in the Western Cape Province of South Africa. 
Eligible participants included patients with a severe mental illness with and without co-
morbid methamphetamine use. A structured interview schedule was used to gather data on
demographic and clinical variables. The KAP-Q sexual risk assessment tool was used to 
assess sexual risk behaviours. The clinician alcohol and drug use scales (AUS, DUS) were
used to assess alcohol and illicit drug use. A comparative analysis of sexual risk behaviours
was conducted between methamphetamine users and non-methamphetamine users. 
Results 
The sample consisted of 100 participants made up of 54 males and 46 females. A total of 40
participants (N=40, 40%) reported methamphetamine use in the past 6 months. Co-morbid 
alcohol use was significantly higher among methamphetamine users (N=27, 67.5%) as
compared to non-methamphetamine users (N=27, 45%) (p=0.027). Similarly, polysubstance
use was also more common among methamphetamine users (N=34, 85%) as compared to 
non-methamphetamine users (N=12, 20%) (p<0.001). The mean age of sexual debut was
significantly earlier among methamphetamine users (mean age in years: 15.75) compared to 
non-methamphetamine users (mean age in years: 18) (p=0.003). During the past 6 months,
sexual intercourse following substance use was more frequent among methamphetamine
users (N=19, 47.5%) compared to non-methamphetamine users (N=15, 25%) (p=0.023).
Transactional sex was significantly more common among methamphetamine users (N=13, 
32.5%) compared to non-methamphetamine users (N=4, 6.7%) (p<0.001). Sex with a
stranger was also significantly more frequent among methamphetamine users (N=19; 47.5%)













In this sample, methamphetamine using mentally ill patients as compared to non-
methamphetamine users more commonly engaged in high risk sexual practices such as earlier 
age of sexual debut, intercourse after using drugs, intercourse with a stranger and 
transactional sex. These results are consistent with international evidence of elevated HIV 
associated sexual risk behaviours amongst patients with dual diagnosis. Furthermore our 
study specifically highlights the heightened HIV risk among methamphetamine using 
mentally ill patients. As such, there should be a greater impetus to screen mentally ill patients 
for HIV risk indicators and a greater frequency of HIV testing and treatment amongst the 
South African mentally ill population. Limitations of this study include the cross-sectional 
design. Substance use was assessed using self-report and not laboratory testing. As such bias 
from symptom minimization and recall inaccuracies among patients cannot be excluded. 
Similar to evidence in developed countries, polysubstance use among methamphetamine 
users is rife and the effect of other substances on HIV associated sexual risk behaviour cannot 
be excluded. The in-patient study population may restrict generalization of results to out- 
patient population groups.  
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Part A: Study Protocol 
 
1.0 Introduction 
1.1 Background and Justification of the study: 
Worldwide, HIV/AIDS remains a priority health concern. In 2011 UNAIDS estimated 34 
million people worldwide were living with HIV. Sub-Saharan Africa continues to carry the 
greatest proportion of the global burden, accounting for 23 million people currently living 
with HIV/AIDS. Roughly translated, this suggests 69% of the world’s total HIV positive 
population lives in Sub-Saharan Africa (Joint United Nations Programme on HIV and AIDS 
[UNAIDS], 2012). Despite the extent of the HIV pandemic, UNAIDS have reported 
significant success of their global preventative and treatment programs with a 50% decline of 
newly infected cases in at least 25 countries across the world. As such, UNAIDS has 
embarked on a mission to achieve zero new cases of HIV infection by 2015. In line with the 
UNAIDS goals, there has been global and local amplification of HIV preventative and 
treatment efforts towards “at risk” groups. In South Africa preventative and treatment efforts 
have been intensified towards young adults, teenage mothers, sex workers and intravenous 
substance users (UNAIDS, 2012). 
There is progressive evidence that mentally ill people have an elevated risk for HIV and bear 
a disproportionate degree of the epidemic as compared to the general population (Meade & 
Sikkema, 2005). Depending on the sample studied, the HIV prevalence amongst mentally ill 
people in the US ranges from 3% to 23% compared to 1% in the general population (Senn & 
Carey, 2009). Of the limited prevalence data available in South Africa, one study reported an 
HIV prevalence rate of 29.1% amongst mentally ill people living in Kwa-Zulu Natal (Singh 
et al., 2002), a rate of almost three times that of the general population. A second study 
reported a 13% prevalence among female inpatients in the Eastern Cape Province (Uys, 
2013) and a third study reported a prevalence of 11% among inpatients at a psychiatric 
hospital in Pretoria (Henning et al., 2012). Mentally ill people in South Africa may therefore 
also form part of a HIV vulnerable population who would benefit from robust HIV 
intervention programs. 
Substance abuse plays a key role in the spread of HIV. HIV infection rates appear higher 
amongst mentally ill people who abuse either non-intravenous or intravenous substances 
compared to those mentally ill people who abstain from substances (Meade & Sikkema, 
2005) The prevalence of alcohol and other illicit substance use disorders amongst mentally ill 
people has been estimated to range from 20% to as high as 75%, depending on the sample 
studied (McKinnon, Cournos, & Herman, 2001). Amongst the South African general 
population alcohol and cannabis remain the most  frequently misused substances (Dada et al., 
2012). Over the past decade, there has been tremendous escalation of methamphetamine use 
in South Africa (Plüddemann, Myers, & Parry, 2008). Approximately 30% of the treatment 
seeking substance using population in South Africa is using crystal methamphetamine 
(Degenhardt et al., 2010) whilst up to 10-13% of South African mentally ill persons 












use triples the risk for HIV infection and transmission amongst mentally ill patients (Meade 
et al., 2008). Both injectable and non-injectable methamphetamine use is associated with 
risky sexual practices (Degenhardt et al., 2010) and therefore also associated with elevated 
HIV risk. 
Smoked crystal methamphetamine is the most common form of methamphetamine used in 
South Africa and produces a rapid, potent and long lasting euphoria (Degenhardt et al., 2010). 
Crystal methamphetamine intoxication is characterized by euphoria, elevated energy levels, 
social confidence and loss of inhibition including sexual disinhibition (Colfax et al., 2010). 
There are high rates of methamphetamine use by groups such as sex workers, homosexual 
and bisexual persons where methamphetamines are used for their ability to enhance erection, 
delay ejaculation and disinhibit the user to allow for greater sexual expression (Colfax et al., 
2010) . In turn, there are several high risk sexual practices found specifically among the 
mentally ill population including: erratic condom usage, multiple sexual partners, prolonged 
sexual sessions, intercourse with strangers and anal intercourse (Colfax et al., 2010). Of note,  
women intoxicated with methamphetamine may specifically experience higher rates of sexual 
coercion (Smit et al., 2006). 
The characteristics of the mental illness itself such as low impulse control, mood lability, 
high hedonistic drives and impaired reality testing may impair ones’ ability to accurately 
interpret events (Meade et al., 2008) and impede ones’ ability to foresee consequences of 
one’s’ behaviour (Grassi, 1996). In this context, methamphetamine induced euphoria and 
sexual disinhibition may further impair one’s ability to correctly interpret events, accurately 
assess sexual risk and ultimately make and execute decisions regarding safe sexual practices 
(Colfax et al., 2010). Avolition and apathy may result in social cognitive deficits where ones’ 
ability to initiate romantic relations is impaired (Carey et al., 2004). As methamphetamines 
are stimulants, they may be used to enhance social confidence and assist in romantic 
partnering (Degenhardt et al., 2010). Where methamphetamines are used to facilitate sexual 
relationships, methamphetamine intoxication may  impede ability to recognize and negotiate 
safer options, thereby increasing the chances of high risk sexual behaviours and therefore of 
HIV (Colfax et al., 2010). Mentally ill people continue to suffer a high degree of social 
stigmatization and economic marginalization (Grassi, 1996). High unemployment rates are 
common amongst the mentally ill and are frequently associated with impoverishment 
(Gordon, Carey, Carey, Maisto, & Weinhardt, 1999). Impecunious living conditions are in 
turn associated with illicit substance use, high rates of interpersonal violence and sexual 
victimization: -  all of which elevate the mentally ill persons’ risk of HIV (Kloos et al., 2005). 
The previously held myth of sexual inactivity amongst the mentally ill has in recent years 
been overturned (Grassi, 1996). Due to several inter-related social, cognitive and 
psychological factors mentally ill people often engage in high risk sexual practices (Meade & 
Sikkema, 2005) including: - irregular condoms usage (Randolph et al., 2007), intercourse 
with persons known for less than a day (Meade, 2006), multiple sexual partners (Randolph et 
al., 2007), transactional sex (McKinnon et al., 2001) and anal intercourse amongst men not 
usually engaging in such sexual acts (Carey et al., 2004). Owing to difficulty attaining and 











relationships and as such they are hesitant to negotiate safe sexual practices (Gordon et al., 
1999).  
There is limited research exploring HIV sexual risk behaviours amongst mentally ill adults in 
South Africa. This sub-population may bear exceptional vulnerability to HIV and therefore 
be deserving of HIV screening and treatment programmes which are especially adjusted to 
meet their needs. Improved HIV detection and treatment programmes may enhance prognosis 
and quality of life as well as impact on global HIV epidemic rates. To our knowledge this is 
the first South African study examining HIV sexual risk behaviours amongst adult patients 
with both mental illness and co-morbid methamphetamine use.  
1.2 Study aim: 
We aim to examine the relationship between sexual risk taking behaviours and co-occurring 
methamphetamine use disorders in patients with severe mental illness.  
1.3 Study Objectives: 
1. To assess sexual risk for HIV/AIDS using a structured questionnaire in patients with
severe mental illness.
2. To measure the presence of methamphetamine use disorder in a group of in-patients with 
severe mental illness.
1.4 Hypothesis: 
We hypothesize that there will be an association between methamphetamine use and sexual 




This will be a cross-sectional study.
2.1(b) Participants and procedures:
Participants will be recruited from the pre-discharge adult in-patient population at 
Valkenberg hospital, a tertiary psychiatric hospital in the Western Cape. Participants will be
recruited from July 2010 to March 2012.
2.2(a) Study inclusion criteria 
1. Participants must be inpatients in the pre-discharge wards between 18 and 59 years of
age.
2. Participants must have a severe mental illness, including: - schizophreniform,
schizophrenia, schizoaffective, brief psychotic disorder, bipolar mood disorders, unipolar
mood disorders with and without psychotic features, substance induced psychotic or
mood disorders or psychotic disorders not otherwise specified. A severe mental illness
must also persist over time and be associated with severe and persistent disability in
social, occupational and other important areas of functioning (Schinnar et al., 1990).












4. Participants must be conversational in English. 
5.  We will aim to include patients who have used methamphetamines in the past 6 months so 
that at least a third of the total sample included such participants. Methamphetamine use was 
defined by a score of 2 or more on the drug use scale. In addition to methamphetamine use 
they can have other substance use disorders. 
2.2(b) Study Exclusion criteria: 
1. Participants unable to understand the purpose of the study 
2. Participants having an organic cognitive mental disorder (i.e. dementia, amnestic 
disorder). 
2.3Measures: 
2.3(a) Demographic and clinical information 
We will collect data on patient’s demographics and related clinical information using a 
structured questionnaire including a record of patients’ multi-axial diagnosis according to 
DSM-IV criteria. 
2.3(b) Sexual risk behaviour:  
We will use the KAP-Q sexual risk assessment tool (Smit et al., 2006). The KAP-Q is a 
structured clinician administered questionnaire that was d veloped in the Cape Town HIV 
Consortium in collaboration with the Desmond Tutu HIV Fund. It has proven validity among 
our local population. This questionnaire assesses sexual risk behaviour for the last 6 months, 
including the following: 
1. Age of sexual debut 
2. Number of sexual partners 
3. Condom usage 
4. Intercourse while intoxicated 
5. High risk behaviours such as intercourse with stranger and transactional sex (intercourse 
in exchange for money/food/accommodation) 
6. STD history 
7. Self-perceived HIV risk 
2.3(c) Drug and alcohol use: 
1. We will use clinician administered rating scales: the clinician administered alcohol use 
scale (AUS) and drug use scale (DUS) (Mueser et al., 1995). These are each 5-point 
scales based on DSM III-R criteria and assess substance use for the past 6 months. The 
scale has proven reliability, sensitivity & specificity in populations of patients with 
serious mental illness (Mueser et al., 1995). All available information including the 
results from the interview, collateral reports, behavioural observations and laboratory 
results will be used obtain the final score on the AUS or DUS for the participant.  
2. The score descriptions are: - 1= abstinence, 2=substance use without impairment, 3= 
substance abuse, 4= dependence, 5=dependence with institutionalization. Participants’ 
substance use was rated using this scale. Amongst participants, methamphetamine use 












drug use scale while methamphetamine use was noted as absent if the participant scored 
less than 2. 
2.4 Data analysis: 
We will conduct a comparative analysis between methamphetamine users and non-
methamphetamine users for various items on the sexual risk questionnaire. We will assess the 
data for deviations from normality by means of the Shapiro-Wilk test for normality. Where 
appropriate, non-normal data will be log-transformed (log10) prior to analysis. Categorical 
data will be analysed using the Chi-square or Fisher’s exact test where appropriate. Normally 
distributed continuous data will be analysed using student’s t-test. Where log transformation 
did not normalise data, we will use the Wilcoxon rank-sum test to analyse non-normally 
distributed data. Significance levels will be set at the 5% level and two-sided tests will be 
used throughout. All data will be analysed using STATA version 11 for windows (StataCorp, 
2009). 
2.5 Sample size: 
We aim for a sample size of a 100 adult inpatients from the pre-discharge wards at 
Valkenberg Hospital. We feel this will be sufficient for data analysis. 
3. Ethics: 
We will seek ethics approval from the Human Research Ethics committee of the University 
of Cape Town. For the purposes of this study Dr A Moodley will be registered as a co-
investigator on a larger umbrella project investigating the presentation, associated risk factors 
and psychobiology of psychosis. This study is currently recruiting patients at Valkenberg 
hospital. Furthermore, this study has received ethics approval in 2008 (UCT Ethics number: 
332/2008). We will therefore apply for ethics approval of an addendum to the latter study. 
The addendum will outline the specific objectives of the HIV risk behaviour sub-study 
described in this protocol, on which Dr Moodley is the main co-investigator. We will in turn 
apply for a separate ethics number for dissertation purposes linked to this sub-study. 
3.1(a) Ethical considerations: 
We considered the following points before seeking ethical approval for this study: 
1. The study procedure should be individually explained and written informed consent is to 
be obtained from each participant. 
2. Confidentiality of each participant shall be maintained by recording the individuals’ 
hospital number (and not their names) as identification on the paper questionnaire. A 
register documenting patients’ name, surname and correlating hospital number will be 
kept for record purposes.  
3. All collated data is to be stored on a secure database on a password protected computer. 
4. No incentive for participation is being offered, and the participant is free to decline and 
can withdraw at any point during the study 












6. If the participant is assessed as high risk for HIV or voices a desire to receive voluntary 
counseling and testing (VCT), a note with permission of the patient, informing the 
primary clinician of this will be made in the patients hospital file. 
7. Any affiliation or conflict of interest between the participant and interviewer (I) will be 
promptly declared. 
3.2 Informed Consent: 
Written informed consent will be obtained from every participant recruited. The study 
procedure will be verbally explained by the investigator to the participant. A written 
paragraph in both English and Afrikaans detailing the rationale behind the study will be 
available for the participant to read before consenting. The investigator will also be available 
to answer questions before and after consent is obtained. 
3.3 Confidentiality: 
All data captured onto our database will be anonymized to protect the confidentiality of our 
participants. There is only one investigator doing field work for this study. 
3.4(a) Potential Benefits: 
Few studies have explored the presence of HIV associated sexual risk behaviour amongst 
mentally ill patients in a South African context. As Sub-Saharan Africa carries the highest 
prevalence of HIV/AIDS in the world, greater preventative efforts must be made in an 
attempt to achieve global UNAIDS target of zero new HIV infection cases by 2015. Care 
must be taken in identifying groups at high risk of contracting HIV and time must be spent in 
examining factors that contribute to the elevated HIV risk of that particular group. It is 
internationally reported that mentally ill patients carry a higher prevalence of HIV/AIDS than 
the general population: - if this were true in South Africa, this would highlight a significant 
group of people whom should receive improved access to HIV testing and treatment and 
improved exposure to preventative efforts in an attempt to reduce South African HIV 
prevalence rates. 
In addition, to the author’s knowledge, there are no local studies, which look specifically at 
the association between methamphetamine use and risk for HIV. Locally methamphetamine 
use increased exponentially and as methamphetamine is known for its effects on sexual 
behaviour, any information regarding its effect on HIV associated high risk behaviours would 
be welcomed in the fight against HIV. 
3.4(b) Potential harms: 
Our questionnaire may prompt realization of one’s HIV risk with subsequent initiation of 
feelings of guilt, anger or depression. We are aware that our participants’ mental illness 
places them at greater emotional and psychological vulnerability and we have attempted to 
limit undue anxiety by selecting participants from pre-discharge wards and by rigorously 
informing and educating participants about the study procedure before participation. 
In addition, all participation will be recorded in the participant’s clinical notes. A note 
informing the treating team of participants HIV risk as gauged from the KAP-Q questionnaire 












We will not offer voluntary counselling and testing to the participants ourselves but will 
encourage the participant to seek testing via the services provided at Valkenberg hospital. 
4. Timelines: 






































Carey, M. P., Carey, K. B., Maisto, S. A., Gordon, C. M., Schroder, K. E. E., & Vanable, P. 
A. (2004). Reducing HIV-risk behavior among adults receiving outpatient psychiatric 
treatment: results from a randomized controlled trial. Journal of consulting and 
clinical psychology, 72(2), 252–268. doi:10.1037/0022-006X.72.2.252 
Carey, M. P., Carey, K. B., Maisto, S. A., Schroder, K. E. E., Vanable, P. A., & Gordon, C. 
M. (2004). HIV risk behavior among psychiatric outpatients: association with 
psychiatric disorder, substance use disorder, and gender. The Journal of nervous and 
mental disease, 192(4), 289–296. 
Colfax, G., Santos, G.-M., Chu, P., Vittinghoff, E., Pluddemann, A., Kumar, S., & Hart, C. 
(2010). Amphetamine-group substances and HIV. Lancet, 376(9739), 458–474. 
doi:10.1016/S0140-6736(10)60753-2 
Dada, S., Pluddemann, A., Parry, C., Bhana, A., Vawda, M., Perreira, T., … Weimann, R. 
(2012). Monitoring alcohol and drug abuse trends in South Africa (July 1966- 
December 2011) Phase 31. SACENDU. Retrieved from 
http://www.sahealthinfo.org/admodule/sacendu/SACENDUBriefJune2012.pdf 
Degenhardt, L., Mathers, B., Guarinieri, M., Panda, S., Phillips, B., Strathdee, S. A., … 
Reference Group to the United Nations on HIV and injecting drug use. (2010). 
Meth/amphetamine use and associated HIV: Implications for global policy and public 
health. The International journal on drug policy, 21(5), 347–358. 
doi:10.1016/j.drugpo.2009.11.007 
Gordon, C. M., Carey, M. P., Carey, K. B., Maisto, S. A., & Weinhardt, L. S. (1999). 
Understanding HIV-related risk among persons with a severe and persistent mental 













Grassi, L. (1996). Risk of HIV infection in psychiatrically ill patients. AIDS care, 8(1), 103–
116. doi:10.1080/09540129650126037 
Henning, M., P., Kruger, C., & Fletcher, L. (2012). HIV sero-positivity in recently admitted 
and long term psychiatric in-patients: prevalence and diagnostic profile. African 
journal of psychiatry, 15, 47–53. 
Kloos, B., Gross, S. M., Meese, K. J., Meade, C. S., Doughty, J. D., Hawkins, D. D., … 
Sikkema, K. J. (2005). Negotiating risk: knowledge and use of HIV prevention by 
persons with serious mental illness living in supportive housing. American journal of 
community psychology, 36(3-4), 357–372. doi:10.1007/s10464-005-8631-1 
McKinnon, K., Cournos, F., & Herman, R. (2001). A lifetime alcohol or other drug use 
disorder and specific psychiatric symptoms predict sexual risk for HIV infection 
among people with severe mental illness. AIDS and Behaviour, 5, 223–240. 
Meade, C. S. (2006). Sexual risk behavior among persons dually diagnosed with severe 
mental illness and substance use disorder. Journal of substance abuse treatment, 
30(2), 147–157. doi:10.1016/j.jsat.2005.11.005 
Meade, C. S., Graff, F. S., Griffin, M. L., & Weiss, R. D. (2008). HIV risk behavior among 
patients with co-occurring bipolar and substance use disorders: associations with 
mania and drug abuse. Drug and alcohol dependence, 92(1-3), 296–300. 
doi:10.1016/j.drugalcdep.2007.07.013 
Meade, C. S., & Sikkema, K. J. (2005). HIV risk behavior among adults with severe mental 
illness: a systematic review. Clinical psychology review, 25(4), 433–457. 
doi:10.1016/j.cpr.2005.02.001 
Mueser, K. T., Nishith, P., Tracy, J. I., DeGirolamo, J., & Molinaro, M. (1995). Expectations 













Plüddemann, A., Myers, B. J., & Parry, C. D. H. (2008). Surge in treatment admissions 
related to methamphetamine use in Cape Town, South Africa: implications for public 
health. Drug and alcohol review, 27(2), 185–189. doi:10.1080/09595230701829363 
Randolph, M. E., Pinkerton, S. D., Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Gibson, R. 
H., & Hackl, K. (2007). Severely mentally ill women’s HIV risk: the influence of 
social support, substance use, and contextual risk factors. Community mental health 
journal, 43(1), 33–47. doi:10.1007/s10597-006-9069-0 
Schinnar, A. P., Rothbard, A. B., Kanter, R., & Jung, Y. S. (1990). An empirical literature 
review of definitions of severe and persistent mental illness. The American journal of 
psychiatry, 147(12), 1602–1608. 
Senn, T. E., & Carey, M. P. (2009). HIV testing among individuals with a severe mental 
illness: review, suggestions for research, and clinical implications. Psychological 
medicine, 39(3), 355–363. doi:10.1017/S0033291708003930 
Singh, D., Vasant, U., Nair, M., G., & Karim, Q., A. (2002). HIV infection among psychiatric 
in-patients in Kwazulu-Natal, South Africa. International conference on AIDS, 7–12. 
Smit, J., Myer, L., Middelkoop, K., Seedat, S., Wood, R., Bekker, L.-G., & Stein, D. J. 
(2006). Mental health and sexual risk behaviours in a South African township: a 
community-based cross-sectional study. Public health, 120(6), 534–542. 
doi:10.1016/j.puhe.2006.01.009 
Stata Corp. (2009). Stata Statistical Software: Release11. College station,TX:StataCorp LP. 














Uys, S. (2013). Prevalence and clinical presentation of HIV positive female psychiatric 
inpatients. African journal of psychiatry, 16, 23–28. 
Weich, L., & Pienaar, W. (2009). Occurrence of comorbid substance use disorders among 
acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. 












Part B: Literature Review 
 
Introduction 
Severe mental illness (SMI) refers to a range of major psychiatric disorders including but not 
exclusive to schizophrenia spectrum disorders, bipolar and unipolar mood disorders (Ruggeri 
et al., 2000; Joint United Nations Programme on HIV and AIDS [UNAIDS], 2012). A severe 
mental illness must persist over time and be associated with severe, persistent disability in 
social, work-related and other important areas of functioning (Schinnar et al., 1990). In the 
developed world, an estimated 30.5% of people are living with mental illness (Kessler et al., 
2005) whilst the lifetime prevalence of common mental disorders in South Africa ranges 
between 9-30% (Stein et al., 2008). 
Patients with severe mental illness have an exceptionally high co-morbidity of substance use 
with lifetime  prevalence ranging between 20-70% (Koola et al., 2012; Regier et al., 1990). 
The phenomenon of mental illness co-occurring with substance use is termed “dual 
diagnosis” (Smith & Hucker, 1993). There may be individual and environmental factors 
which increase the likelihood of both dual diagnosis (Dixon et al., 1991)  and risk taking 
behaviours. Among these risk taking behaviours are sexual risk behaviours which facilitate 
risk for sexually transmitted diseases including human immunodeficiency virus (HIV) 
(Devieux et al., 2007).  
Since the early 1980’s, HIV has rapidly progressed to pandemic proportion (UNAIDS, 2012). 
By 2011 there were 34 million people living with HIV worldwide. Approximately  69% of 
the global HIV positive population live in Sub-Saharan Africa (UNAIDS, 2011) within 
which, South Africa has the highest total population prevalence rate of 11% (UNAIDS, 
2011). 
The Joint United Nations HIV/AIDS Programme, UNAIDS, has envisioned a goal of zero 
new HIV infection cases by 2015 (UNAIDS, 2011). Consequently there has been an 
amplification of  global HIV preventative and treatment efforts towards “at risk” populations  
(UNAIDS, 2011). Multiple mechanisms such as socio-demographic factors, characteristics of 
the mental illness and the phenomenon of dual diagnosis elevate the vulnerability of the 
mentally ill population to HIV (Carey et al., 2004; Meade, 2006). The presence of co-morbid 
physical illnesses such as HIV aggravates the disability associated with severe mental illness 
(Atkinson et al., 2009; Freeman, Patel, Collins, & Bertolote, 2005; UNAIDS, 
2011).Prevention of HIV or early identification and treatment is essential in  attaining overall 
wellbeing and improved prognosis in this vulnerable population  (Grassi, 1996; Mamabolo et 
al., 2012; Meade & Sikkema, 2005). 
Methamphetamine use in South Africa 
Globally 15-60 million people use methamphetamines at least once in their lifetime, making 
methamphetamines the most frequently used illicit stimulant in the world  (Rawson, Anglin, 
& Ling, 2002; UN office on Drugs and Crime [UNODC], 2009). The South African 












and other illicit substance use among the general population since 1996 has reported that 
alcohol followed by cannabis are the most frequently used substances in South Africa  (Dada 
et al., 2012). Since the abolishment of apartheid and restitution of international trade 
agreements, illicit methamphetamine use in South Africa has significantly increased (Dada et 
al., 2012). Among the South African treatment seeking population, the Western Cape has the 
fastest growing prevalence of methamphetamine use increasing from 0.3% in 2002 to more 
than 30% in 2011 (Dada et al., 2012; Degenhardt et al., 2010).  Prevalence of 
methamphetamine use among mentally ill populations in Western Cape, South Africa ranges 
between 10-13% (Weich & Pienaar, 2009), which is comparable to the prevalence range of 
10-25% among psychiatric populations in North-America and Asia (Koola et al., 2012). 
Since 1996, SACENDU has consistently recorded the highest methamphetamine use among 
young adults with the  mean age for the period 2006-2013 ranging between 22-26 years of 
age (Dada et al., 2012). Gender trends among methamphetamine users have also remained 
consistent since the mid 1990’s. SACENDU has recorded twice as many males compared to 
females seeking treatment for methamphetamine abuse in the Western Cape (Dada et al., 
2012).The gender distribution for alcohol and cannabis users in the Western Cape  is similar 
to that of methamphetamine users with males outnumbering females, 70%: 30% (Dada et al., 
2012).  
Globally methamphetamines are available in several forms ranging from powder to crystals. 
As a result there are several modes of use including, oral, snorting, inhalation, intravenous 
injection, intra-rectal and intra-vaginal application (Maxwell, 2005; Vearrier et al., 2012). In 
South Africa the crystalline form of methamphetamine is most widely used and smoking or 
inhalation is the favoured mode of use (Degenhardt et al., 2010). Crystal Methamphetamine 
is “colloquially named “tik”  after the sound it makes when smoked (Peltzer et al., 2010). 
Compared to other modes of use, smoked crystal methamphetamine produces the quickest 
blood absorption followed by the fastest release of dopamine at the central nervous system. 
The dopamine released produces an intense euphoria with potent re-inforcing effect 
(Degenhardt et al., 2010). Crystal methamphetamine intoxication is characterised by 
euphoria, increased energy levels, hypervigilence, social gregariousness, hypersexuality and a 
sense of invulnerability (Colfax & Shoptaw, 2005).  
 
Factors facilitating methamphetamine use amongst patients with severe 
mental illness    
A variety of individual, environmental, social and biological factors facilitate 
methamphetamine use among mentally ill patients. Individual factors may include either 
endogenous factors such as age and gender or exogenous factors such as early life trauma, co-
morbid psychiatric disorders, personality style, poor problem solving abilities and preceding 
use of gateway drugs (Gregg, Barrowclough, & Haddock, 2007). Current literature reports 
that majority of global methamphetamine use occurs among young people less than 20 years 
old (Dada et al., 2012; Marshall et al., 2011; Peltzer et al., 2010). In South Africa, young 












Peltzer et al., 2010). Therefore being a young male in South Africa may increase ones’ 
proclivity for methamphetamine use. Reasons for methamphetamine use cited by both 
genders in the general population include: “wanting to get high”, “to party” and “to 
experiment” (Semple et al., 2004). Female methamphetamine users were more likely than 
males to offer additional reasons such as: to lose weight, to feel attractive and to cope with 
depressed mood (Semple et al., 2004). These findings need to be replicated in psychiatric 
populations. The self-medication theory posits that illicit substances are used to alleviate 
unwanted symptoms. Negative psychotic symptoms, depressed mood and medication side 
effects particularly sexual side-effects are commonly self-medicated by psychiatric patients. 
There is evidence that methamphetamines are used by psychiatric patients to self-medicate 
anhedonia,  avolition and low energy levels (Dixon et al., 1991). Methamphetamines are also 
used particularly by male patients (Dixon et al., 1991) to combat sexual inadequacies by 
enhancing erection, delaying ejaculation and increasing energy levels for prolonged 
intercourse (Colfax & Shoptaw, 2005). Primary or secondary negative symptoms may hinder 
one’s social skills and impair  ones’ ability to initiate romantic relationships (Dixon et al., 
1991; Gordon et al., 1999).  Methamphetamine induced talkativeness and social gregarity 
may remedy impaired social interactional skills (Dixon et al., 1991)  and thereby help secure 
romantic relationships (Meade,  2006). On the other hand, patients lacking assertiveness may 
be easily coerced into substance use (Gordon et al., 1999; Meade, 2006). There is evidence 
that users are commonly introduced to methamphetamine by their friends and romantic 
partners (Sheridan et al., 2009). The use of “gateway drugs” such as tobacco, alcohol and 
cannabis preceding methamphetamine use is reported by mentally ill populations (Reid et al., 
2007). “Gateway drugs” are called so because they pave the way for use of “hard” drugs such 
as methamphetamine (Russell et al., 2008). The combined effect of several characteristics 
inherent to certain mental illnesses such as low impulse control, novelty seeking, mood 
lability, high hedonistic drives and impaired reality testing may intensify the salience of 
immediate substance induced euphoria and impair ones’ ability to foresee distal 
consequences of substance using behaviour (Carey et al., 2004; Meade, Graff, Griffin, & 
Weiss, 2008). Early childhood trauma specifically childhood sexual abuse (CSA) is a 
recognized precipitant of both methamphetamine use (Marshall et al., 2011) and mental 
illness (Grubaugh et al., 2011). There may therefore be a proportion of mentally ill people 
with a history of CSA, where the CSA prompts methamphetamine use as a form of self-
medication (Halkitis & Shrem, 2006).  
Social and environmental factors  such as stigmatization and economic marginalisation which 
are common among patients with severe mental illness (Grassi, 1996; Kawakami et al., 2012; 
Kessler et al., 2008) may indirectly lead to substance use. Methamphetamine may be used to 
either induce euphoria and alleviate dysphoria or used to induce social gregarity in an attempt 
to forge friendships and alleviate social rejection (Dixon et al., 1991; Gottesman & Groome, 
1997). Large proportions of mentally ill patients have cited wanting “to fit in with the crowd” 
and “to feel good” as main reasons motivating meth/amphetamine use (Baker et al., 2002; 
Gregg et al., 2007).  Economic marginalisation associated with low education levels and loss 
of functioning due to chronic progressive course of severe mental illness may lead to patients 











common (Kawakami et al., 2012; Kessler et al., 2008). The ease of access to illicit substances 
coupled with poor impulse control, a characteristic common to a variety of mental illnesses 
(Carey et al., 2004) elevates the risk for substance use (Mueser et al., 1995). Poverty and 
unemployment are associated with boredom, unfulfilled expectations and disillusionment. 
Methamphetamines among other psychoactive substances may provide temporary escapism 
from the harsh reality of poverty (UNODC, 1999).The relatively weak South African drug 
law enforcement (Gregg et al., 2007), cheap and easy manufacture process (Gregg et al., 
2007) and increasing demand make methamphetamine one of the easiest accessible “hard” 
drugs in South Africa (Dada et al., 2012). As a result, there is increasing social exposure to 
methamphetamine use and decreasing societal discrimination against its use.  
Methamphetamine use and HIV associated sexual risk behaviour
Both injectable and non-injectable methamphetamine use increases the likelihood of sexual
risk behaviours with increased risk for sexually transmitted diseases including HIV (Maher et
al., 2011; Parry et al., 2009; Treutlein & Rietschel, 2011). There are several direct and
indirect mechanisms linking methamphetamine use with HIV associated sexual risk
behaviours (HASRB). Methamphetamine intoxication produces physiological and
behavioural effects which enhance likelihood of sexual encounters. Behavioural effects such
as intoxication induced euphoria, social gregariousness and talkativeness (Colfax & Shoptaw, 
2005; Maxwell et al., 2005) may promote interpersonal relationships whilst hypersexuality
secondary to methamphetamine use (Colfax & Shoptaw, 2005; Reback, Larkins, & Shoptaw,
2004) may facilitate progression of interpersonal relations to sexual encounters. Direct sexual 
enhancing physiological effects of methamphetamine include enhanced erectile function,
delayed ejaculation and prolonged intercourse ability. Whilst the majority of evidence of 
methamphetamines’ physiological sexual enhancing effects come from female sex worker
(Maher et al., 2011), men who have sex with men (MSM)( Parry et al., 2008) and adolescents 
populations ( Degenhardt et al., 2010; Plüddemann, Myers, & Parry, 2008 ) there is evidence
of sexual enhancing effects motivating methamphetamine use emerging from mentally ill
populations (Baker et al., 2002). There is more evidence of physiological male sexual 
enhancement as compared to female sexual enhancement (Plüddemann et al., 2008; Semple, 
Patterson, & Grant, 2002). As such, there may be gender differential sexual risk behaviours 
among methamphetamine users. Sex marathons, compulsive sexual behaviour where one
appears unable to control ones sexual behaviour, multiple sexual partners (Semple et al., 
2002), anal intercourse with a partner of unknown or opposite sero-status (Colfax et al.,2001)
and unprotected anal intercourse (Colfax et al., 2010) have been reported by males,
particularly MSM, using methamphetamines. Higher number of sexual partners, multiple 
partners, buying sex, using the same condom whilst exchanging partners and irregular
condom use are reported more frequently among heterosexual males than heterosexual
females using methamphetamine (Liu et al., 2013). Methamphetamine use among females 
increases likelihood of anal intercourse among women not usually participating in such 
sexual activities (Stockman & Strathdee, 2010). There is also higher rates of sexual coercion











Methamphetamine use is also associated with earlier age of sexual debut (Plüddemann et al.,
2008; Springer et al., 2007) and transactional sex, where sex is exchanged for
money/drugs/accommodation ( Colfax et al., 2010; Semple et al., 2011). Earlier sexual debut 
and transactional sex are referred to as contextual risk factors which carry increased risk of
HIV (UNAIDS, 2011). Female methamphetamine users more commonly report exchanging
sex for drugs/money (transactional sex) than male methamphetamine users (Semple et al.,
2011). Trading sex is associated with several HIV risk behaviours including: having anal sex
among those not usually participating in such practices (Reynolds, Latimore, & Fisher, 2008), 
sexual victimization as adults (Church et al., 2001) and childhood sexual abuse (Arriola et
al., 2005). Female sex workers in South Africa frequently use methamphetamine before,
during and after sexual activities (Parry et al., 2008). This is likely for its ability to prolong 
intercourse and reduce inhibitions (Colfax et al., 2010). Prolonged intercourse increases
likelihood of vaginal or anal trauma which increases risk for sexually transmitted diseases 
including HIV (Colfax et al., 2010). Methamphetamine use is also independently linked to
increased likelihood of condom breakage (Stone et al., 1999). Methamphetamine intoxication
imparts a sense of invulnerability which when coupled with intoxication induced 
hypersexuality (Colfax & Shoptaw, 2005) may reduce concerns for safe sex practices (Colfax 
& Shoptaw, 2005). The pharmacological degrading effects of acute intoxication may further
impair decision making skills around safe sex practices (Scott, 2012). Decision making may
be additionally impaired by neuro-structural changes secondary to chronic methamphetamine
use (Grant et al., 2012). Majority of methamphetamine associated sexual risk behaviour
literature is based on MSM or sex worker populations with limited data available from 
mentally ill populations. It is therefore difficult to extrapolate findings to the mentally ill
population.
Mental illness and HIV associated sexual risk behaviour
The HIV prevalence rate is as much as three times higher amongst mentally ill people than
the general population (Rosenberg et al., 2001). North American HIV prevalence rates range
between 4-23% among mentally ill patients compared to 1% among the general population 
(Meade & Sikkema, 2005). Depending on the sample studied, prevalence among mentally ill 
patients in South Africa range between 11-29% (Henning et al., 2012; Singh et al., 2002;
Uys, 2013). Previously held myths of sexual inactivity amongst the mentally ill have been
dispelled. In a review of HIV risk behaviour among mentally ill people, Meade and Sikkema
(Meade & Sikkema, 2005) reported that 50-74% of all patients had been sexually active in 
the preceding year. Additional evidence show that the majority of sexual activity amongst
mentally ill patients is unsafe conferring increased risk for HIV (Carey et al., 1997; Grassi, 
1996). HIV associated sexual risk behaviours documented among severely mentally ill 
patients include; erratic condom usage (Carey et al., 1997; McKinnon, Cournos, & Herman,
2002), transactional sex (Kalichman et al., 1994; McKinnon et al., 2002; Meade & Sikkema,
2005), sexual intercourse with strangers/casual sex (Carey et al., 1997), forced sexual activity
(Carey et al., 1997; McKinnon et al., 2002), having a non-HIV sexually transmitted disease












Meyer-Bahlburg, 1993; Gottesman & Groome, 1997). A systemic review of HIV risk 
behaviours among psychiatric patients in 2005 reported gender differences for several high 
risk behaviours  (Meade & Sikkema, 2005). Women with SMI are more commonly sexually 
active within a steady relationship whilst men with SMI are more likely to have casual sexual 
relationships (Meade & Sikkema, 2005). Having a lifetime STD history, unprotected sex and 
transactional sex is more common among women with SMI whilst paying for sex is more 
common among men with SMI (Meade & Sikkema, 2005). Meade and Sikemma (Meade & 
Sikkema, 2005) did not find consistent gender differences for having multiple sexual 
partners. An earlier review by McKinnon, Cournos & Herman (McKinnon et al., 2002) also 
failed to demonstrate consistent gender differences for multiple partners and receptive anal 
sex. A recent study which sampled only women with SMI reported high rates of transactional 
sex, sexual coercion and sex with a partner known/suspected of being sexually unfaithful 
among participants (Randolph et al., 2007). Meade and Sikkema (Meade & Sikkema, 2005) 
reported significant negative correlation between age of patient and sexual activity but failed 
to significantly correlate age with multiple partners, condom usage and transactional sex. 
Despite socio-occupational functional decline (Gould, Bowie, & Harvey, 2012) and presence 
of positive or negative symptoms, sexual interest persists among mentally ill patient (Hales et 
al., 2006). Negative symptoms and poor cognitive functioning among severely mentally ill 
patients may impair decision making and negotiation skills around safe sex practices (Gordon 
et al., 1999). Patients, particularly women with severe mental illness may lack assertiveness 
skills and in turn be easily coerced into unsafe sexual practices (Gordon et al., 1999; 
Randolph et al., 2007). Impaired social skills make it difficult for mentally ill patients to 
attain and maintain romantic relationships (Gordon et al., 1999). There may be gender 
differential effects on social skills and sexual behaviour. Men need social skills to initiate 
romantic relationships whilst women need social assertiveness skills to avoid sexual coercion 
(Weinhardt et al., 1999). Mentally ill patients struggling to attain romantic relations may 
negotiate sexual relationships with fellow patients whilst at mental health facilities 
(Kalichman et al., 1994). Periodic same-sex intercourse is more common among male 
psychiatric patients than female patients (McKinnon et al., 2002). There is limited access to 
condoms within psychiatric hospital setting resulting in higher rates of unprotected 
intercourse (McKinnon et al., 2002). Limited social skills among patients may also increase 
the likelihood of having casual sex and sexual encounters with strangers (Katz, Watts, & 
Santman, 1994). Hypersexuality and poor impulse control during a manic episode (American 
Psychiatric Association, 2000) may offer some explanation for the high rates of unprotected 
sex, transactional sex and multiple partners (Stewart et al., 2012) In psychosis, positive 
symptoms such as psychotic agitation and excitement are associated with increased rates of 
sexual behaviour (Meade & Sikkema, 2005). Depression may be associated with lack of 
motivation to change unsafe sexual practices whilst self-destructive behaviours (Grassi, 
1996) may include deliberate practice of unsafe sex.  
Knowledge of HIV transmission and sexual risk behaviours are significantly low among 
mentally ill patients (Carey et al., 2004; Koen et al., 2007). Negative symptoms are 











al., 2007). In addition, patients may have incorrect assumptions regarding HIV transmission 
such as that only men who have sex with men are at risk and that HIV infected sexual 
partners always look physically ill (Koen et al., 2007). Mentally ill patients therefore often 
underestimate their risk for HIV infection resulting in inadequate practice of safe sex (Koen 
et al., 2007).   
Despite international mental illness awareness programmes, social stigmatization of mentally
ill patients remains rife (Jackowska, 2009). Stigmatization may foster social isolation 
(Baumann, 2007) . As a result sexual encounters among mentally ill people may serve to
satisfy emotional needs thereby reducing likelihood of assertiveness around safe sex (Gordon
et al., 1999). Economic marginalization secondary to stigma, progressive course of illness
and low education level is common among the mentally ill (Kessler et al., 2008). Patients 
may hesitate to insist on safe sexual practices in fear of jeopardizing relationships which meet 
emotional and financial needs (Gordon et al., 1999). Poverty may motivate transactional sex
among severely mentally ill patients (Gottesman & Groome, 1997; Kalichman et al., 1994;
Meade & Sikkema, 2005).
HIV Risk amongst severely mentally ill patients who abuse
methamphetamine
The high HIV prevalence rate among mentally ill patients is elevated three times further by
co-occurring substance use (Rosenberg et al., 2001).Co-morbid substance use including 
methamphetamine use may reflect underlying personality characteristics associated with risk 
taking (Lejuez et al,. 2004). Risk taking behaviours may extend beyond substance use and
into HIV associated sexual risk behaviours such as sex with strangers and multiple partners
(Meade, 2006). HIV associated sexual risk behaviours (HASRB) reported by psychiatric
patients with substance use disorders (inclusive of but not exclusive to methamphetamine
use) include unprotected intercourse, lifetime STD history (Meade & Sikkema, 2005), 
transactional sex (McKinnon et al., 2002), multiple partners (Gottesman & Groome, 1997), 
unprotected anal intercourse among heterosexual and homosexual mentally ill patients 
(Susser et al., 1995) and sexual coercion (Kalichman et al., 1994). Hampton et al. found that
intravenous methamphetamine use among psychiatric patients was associated with poly-
substance use and with having intercourse with anonymous partners (Hampton, Chafetz, &
Portillo, 2012). In a review by Meade and Sikkema (Meade & Sikkema, 2005), a range of
substances inclusive of but not exclusive to methamphetamine use, positively correlated to
current sexual activity among mentally ill patients. This review found no specific associations 
between meth/amphetamine and sexual risk behaviours (Meade & Sikkema, 2005). An earlier
review by McKinnon et al. reported that co-morbid alcohol or other substance abuse disorder
was associated with transactional sex among psychiatric patients (McKinnon et al., 2002)
where transactional sex was characterised by the following gender differences: men with SMI
and substance use disorders were more likely to sell drugs for sex whilst female patients were
more likely to sell sex in exchange for drugs. McKinnon et al. did not report any specific
association between meth/amphetamine and sexual risk behaviours (McKinnon et al., 2001). 











HASRB among psychiatric patients, there are studies which report associations between other 
psycho-stimulants such as cocaine or crack cocaine and HASRB. Men with SMI who use 
crack cocaine have increased likelihood of having unprotected intercourse and sex with a 
high risk partner (McKinnon et al., 2002). Men with SMI who use cocaine  report more 
erratic condom usage (McKinnon et al., 2002), multiple partners and buying sex (Meade et 
al., 2008) compared to women with SMI and cocaine use who reported  higher rates of selling 
sex (Meade et al., 2008). Literature therefore does depict associations between HASRB and 
stimulant type psychoactive substances. Based on the similar intoxication effects of 
meth/amphetamine and cocaine, these two psycho-active substances may share common 
effects on sexual function but it would be inaccurate to generalise HASRB associations with 
cocaine to meth/amphetamine. Further research focusing on associations between 
meth/amphetamine use and HASRB among psychiatric patients is therefore needed.  
Mania shares similar characteristics to methamphetamine intoxication: elevated mood/
energy levels, hypervigilence, increased social confidence , hypersexuality and a sense of
invulnerability (Colfax & Shoptaw., 2005; American Psychiatric Association, 2000). 
Methamphetamine intoxication may therefore exacerbate hypersexuality, impulsivity and 
poor judgement associated with mania thereby increasing likelihood of sexual risk behaviours
such as transactional sex and multiple partners (Meade et al., 2008).Positive symptoms may
be exacerbated by methamphetamine use (Bramness et al., 2012) thereby increasing the
severity of mental illness. The greater the severity of the illness, the worse the social
assertiveness and decision making skills become (Gordon et al.,1999) resulting in higher rates 
of sex after substance use and higher rates of erratic condom usage (Randolph et al. 2007).
Negative symptom relief by methamphetamine may facilitate romantic partnering (Meade,
2006). Substance initiated relationships are characterised by conflict and instability which in 
turn may lead to relationship break-ups and rapid partner turnover (Meade, 2006) thereby
elevating number of sexual contacts and HIV risk. The impaired cognitive skills of severe
mental illness (Koen et al., 2007) may be worsened by acute methamphetamine intoxication 
(Scott et al., 2007) resulting in further impairment of decision making ability around safe
sexual practices.
Stigma exists toward mental illness(Jackowska, 2009) and toward substance use (Link et al., 
1997). Therefore dual diagnosis patients may be ‘doubly marginalized’. These individuals 
may tolerate high risk sexual practices in an attempt to decrease social isolation and 
loneliness (Gordon et al., 1999; Stockman & Strathdee, 2010) Mental illness is associated 
with low earning potential (Kessler et al., 2008) while substance use is associated with low 
employment rates (Humensky et al., 2013), therefore poverty is common among dual 
diagnosis patients. As a result of poverty, substance using mentally ill patients commonly 
report transactional sex (Devieux et al., 2007). 
Meth/amphetamine use in psychiatric patients frequently occurs in the context of 
polysubstance abuse (Hampton et al., 2012; Katz et al., 1994). It therefore is important to be 
aware of associations between other non-methamphetamine substances and HASRB in 
psychiatric patients. Alcohol use among psychiatric patients is common (Weich & Pienaar, 












morbid alcohol use among psychiatric patients is associated with unprotected sexual 
intercourse (Meade & Sikkema, 2005). Mentally ill women who use alcohol before or during 
sex are also more likely to participate in anal intercourse (McKinnon et al., 2002). Alcohol 
use by both genders is associated with higher likelihood of being sexually active (Devieux et 
al., 2007), transactional sex and casual sex (Smit et al., 2006). Lifetime substance use 
disorder (inclusive of but not exclusive to alcohol use) was associated with increased 
likelihood of having a STD (Meade & Sikkema, 2005; McKinnon et al., 2001).There are 
equivocal results for cannabis use in association with HASRB (Devieux et al., 2007). Psycho-
stimulants such as crack cocaine were strongly associated with having sex with a high risk 
partner and unprotected intercourse among men with SMI (Mckinnon et al., 2002). Overall, 
there is substantial evidence identifying mentally ill patients with co-morbid substance use 
disorder as having exceptional vulnerability for HIV infection(Meade, 2006) . 
 
Gaps in current research and areas in need of attention 
Despite South Africa having one of the highest HIV prevalence rates in the world, there is a 
paucity of research on HIV trends among mentally ill South Africans (UNAIDS 2012). 
Additionally there is very limited South African information on methamphetamine use 
among mentally ill patients (Vos et al., 2010; Weich & Pienaar, 2009).Thus far, South 
African literature in contrast to American literature (Meade 2006; Randolph et al., 2007) has 
not clearly illustrated that the sexual effects of crystal methamphetamine are the primary 
motivation behind its use among mentally ill persons. 
Although there is a multitude of studies examining the relationship between substance use, 
mental illness and HIV risk (McKinnon et al., 2002; Meade & Sikkema, 2005; Otto-Salaj et 
al., 1998), very few studies have looked specifically at the effect of non-intravenous 
methamphetamine use on HIV sexual risk behaviours among patients with SMI. Meade 
(Meade, 2006) and Randolph (Randolph et al., 2007)  reported that substance use including 
amphetamine use among mentally ill patients was associated with elevated rates of HIV 
associated sexual risk behaviours such as erratic condom usage and multiple partners. 
However, neither Meade (Meade, 2006) nor Randolph (Randolph et al., 2007) distinguished 
methamphetamine using patients from non-users and neither reported HIV associated sexual 
risk behaviours specifically associated with methamphetamine usage. Hampton et al. 
(Hampton et al., 2012) examined sexual risk behaviours among dual and triple diagnosed 
mentally ill patients. Dual diagnosis referred to co-morbid substance use disorders including 
intravenous amphetamines whilst triple diagnosis referred to dual diagnosis and HIV or 
Hepatitis C (Hampton et al., 2012). Hampton et al. (Hampton et al., 2012) reported that 
intravenous amphetamine use was 2.6 times more frequent among those with triple diagnosis 
than those with dual diagnosis. Among patients with SMI, specific associations between 
intravenous amphetamine use and sex with a stranger were reported (Hampton et al., 2012). 
No further associations between amphetamine use and other HIV associated sexual risk 
behaviours were reported (Hampton et al., 2012). Intravenous methamphetamine use is 
uncommon in South Africa (Dada et al., 2012), therefore making it difficult to generalise 












HIV sexual risk behaviours among other HIV vulnerable groups such as men who have sex 
with men (Colfax et al., 2010; Reback et al., 2004), there is an urgent need for exploration of 
the effects of non-intravenous methamphetamine use on sexual behaviour among mentally ill 
patients. There is emerging evidence of a high HIV prevalence among mentally ill patients in 
South Africa (Henning et al., 2012; Singh et al., 2002; Uys, 2013). There is therefore a vital 
need for improved HIV detection and management among local mentally ill patients. Greater 
exploration of the effect of substances such as methamphetamine on sexual behaviour among 
mentally ill patients may help tailor HIV prevention and treatment programmes to meet the 
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Abstract of Journal Article 
 
There is substantial evidence that persons with serious mental illness shoulder a 
disproportionate share of the HIV pandemic. In South Africa, and most notably, in the 
Western Cape, methamphetamine use has exponentially increased over the last decade. Use 
of methamphetamine among HIV vulnerable populations such as the mentally ill, has been 
associated with higher rates of sexual risk behaviours. The South African HIV epidemic is 
largely sexually transmitted and as such methamphetamine associated sexual risk behaviours 
may fuel the HIV epidemic among mentally ill patients. Recognition of methamphetamine 
associated sexual risk behaviours, may guide HIV prevention and treatment interventions. 
This study assessed methamphetamine use and explored the relationship between 
methamphetamine use and sexual risk behaviours among 100 psychiatric inpatients in the 
Western Cape. Results confirmed that compared to non-methamphetamine using patients, 
methamphetamine using mentally ill patients were significantly more likely to report sexual 
risk behaviours such as: earlier age of sexual debut, transactional sex, sex with a stranger and 
sex following substance use. The study highlights the urgent need for design and 
implementation of HIV intervention programmes which meet the special needs of the 
mentally ill. In the meantime, improving the frequency of voluntary testing and counselling 
to those with mental illness and ensuring delivery of HIV/AIDS awareness programmes at all 
levels of mental health care delivery in South Africa will assist mentally ill patients in the 
fight against HIV/AIDS. 
Keywords:  mental illness; HIV; methamphetamine; sexual risk behaviour; South Africa 























For more than a decade there has been growing evidence that mentally ill people have an 
elevated risk for HIV (Campos et al., 2008; Grassi, 1996; Kalichman et al., 1994; McKinnon, 
Cournos, & Herman, 2002; Meade & Sikkema, 2005b). South Africa accounts for one of the 
highest HIV prevalence rates in the world with an estimated 11% total population prevalence 
rate (UNAIDS, 2011). Depending on the sample studied, the prevalence of HIV among South 
African mentally ill patients ranges between 11-29% (Henning, Kruger, & Fletcher, 2012; 
Singh et al., 2002; Uys, 2013). A study in 2002 reported a HIV prevalence in persons with 
severe mental illness (SMI) of up to three times that of the general population (Singh et al., 
2002). 
South African Community Epidemiology Network on Drug use, SACENDU, reports non-
intravenous substance use is more frequent than intravenous substance use in South Africa 
(Dada et al., 2012). Since the renewal of international trade agreements in the early 1990’s, 
illicit methamphetamine (MA) use in South Africa has exponentially increased (Pasche & 
Myers, 2012).The Western Cape province in South Africa has the highest rates of MA use 
where the estimated proportion of treatment seeking users increased from 0,3% in 2002 to 
35% in 2011 (Degenhardt et al., 2010; Plüddemann, Myers, & Parry, 2008; Dada et al., 
2012). Methamphetamine intoxication is characterised by euphoria, elevated energy levels, 
insomnia, anorexia, increased libido (Scott et al., 2012),elevated social confidence and sense 
of invulnerability (Colfax & Shoptaw, 2005). 
In South Africa, HIV/AIDS is predominantly heterosexually transmitted (Gouws & Cuchi, 
2012; UNAIDS, 2011). Non-intravenous MA use is associated with  sexual risk behaviours 
such as earlier age of sexual debut (Springer et al.,  2007), erratic condom usage (Halkitis, 
Parsons, & Stirratt, 2001), multiple partners (Semple et al.,  2011), sexual intercourse with 
strangers and transactional sex where sex is exchanged for money/accommodation/ 
substances (Semple et al., 2011). There is emerging reports particularly from male psychiatric 
patients (Dixons et al., 1991) backing the already substantial evidence base  from sex worker 
(Maher et al., 2011) and homosexual populations (Degenhardt et al., 2010) that MA use is 
favoured for its sexual enhancing effects of sexual disinhibition, prolonged erection, delayed 
ejaculation and prolonged intercourse (Degenhardt et al., 2010; Maxwell, 2005). Prolonged 
intercourse may be associated with vaginal or anal trauma and HIV transmission (Colfax et 
al., 2010). Co-occurrence of MA use and sexual risk behaviours may be explained by a 
combination of: underlying personality traits such as impulsivity (Meade, 2006) and 
intoxication associated increased libido, impaired decision making ability (Grant et al., 2012) 
and sense of invulnerability (Colfax and Shoptaw, 2005). Among chronic MA users, decision 
making skills may be further impeded by structural neural changes secondary to chronic use 
(Grant et al., 2012). 
Co-morbid substance use disorders occur in up to 70% of all individuals with severe mental 
illness (SMI) (Koola et al., 2012; Regier et al., 1990). A recent study in Western Cape, South 











Pienaar, 2009), which is comparable to international methamphetamine prevalence rates of 
10-25% amongst mentally ill persons (Kloos et al., 2005).Co-morbid substance use may be
driven by novelty seeking and impulsive behaviour characteristic of mania (Meade et al., 
2008). Alternatively, substances may be used to relieve negative symptoms and to enable 
display of emotions, enable patient to talk more, to be more creative (Dixon et al., 1991) and
to facilitate romantic relationships (Meade, 2006). Substance initiated relationships are
however, characterized by greater conflict (Meade, 2006) greater sexual infidelity and
frequent partner turnover (Meade, 2006) thereby increasing the risk for HIV transmission. 
Additionally, a lack of negotiation skills among patients may allow coercion into substance
use (Gordon et al., 1999). Assertiveness skills for safer sexual practices may be further
impaired by intoxication (Gordon et al., 1999; Meade et al., 2005b). Fear of jeopardizing an 
emotionally or financially supportive relationship may reduce patient’s insistence on safe sex
practices (Gordon et al., 1999). There is substantial evidence of methamphetamine associated
sexual risk behaviours amongst sex workers and men who have sex with men, but no local 
studies and few international studies were found assessing HIV associated sexual risk
behaviours (HASRB) in the context of methamphetamine use amongst severely mentally ill
persons. Meade (Meade, 2006) found that current or lifetime substance use including 
amphetamine use, significantly raised the likelihood of HASRB among mentally ill patients . 
Randolph et al. elicited that substances, including amphetamines, were associated with higher
frequencies of unprotected sex and multiple partners among women with SMI (Randolph et 
al., 2007). Neither Meade (Meade, 2006) nor Randolph et al. (Randolph et al., 2007)
distinguished amphetamine users from other substance users and neither reported HASRB
specifically associated with methamphetamine use. Hampton et al. (Hampton, Chafetz, &
Portillo, 2012) examined sexual risk behaviours among dual and triple diagnosed mentally ill
patients where triple diagnosis referred to dual diagnosis (mental illness and co-morbid
substance use disorder) and HIV or Hepatitis C (Hampton et al., 2012). Hampton et al.
(Hampton et al., 2012) reported that intravenous amphetamine use was more frequent among 
those with triple diagnosis than those with dual diagnosis. Among patients with SMI, a strong 
association between intravenous amphetamine use and sex with a stranger were reported 
(Hampton et al., 2012). No further associations between amphetamine use and other HIV
associated sexual risk behaviours were reported in the study by Hampton et al. (Hampton et 
al., 2012). There is substantial evidence that persons with severe mental illness who also 
misuse alcohol or illicit substances other than methamphetamines have as much as 3 times 
elevated risk of HIV (McKinnon, Cournos, & Herman, 2001; Meade et al., 2005b; Meade,
2006; Meade et al., 2008; Rosenberg et al., 2001). Given the paucity of research on
methamphetamine use and HASRB, we aimed to describe methamphetamine use and HIV
associated sexual risk behaviours (HASRB) amongst a South African population of mentally
ill inpatients. We further aimed to explore the relationship between sexual risk behaviours
and co-occurring methamphetamine use disorders among mentally ill patients. We
hypothesized that there will be a significant association between sexual risk behaviours and













Sample and participants 
This is a cross-sectional study which was conducted between July 2010 and March 2012 in 
the Western Cape, South Africa. This study received ethical approval from the ethical review 
board of the University of Cape Town, Medical School. A total of 100 participants were 
recruited from the adult inpatient population at Valkenberg Hospital which is a state 
secondary level psychiatric hospital operating in the central health district of the metro region 
of the city of Cape Town (www.westerncape.gov.za, 2012). Participants were aged between 
18-59 years old and had to have a severe mental illness. All participants had to be 




For the purposes of this study, severe mental illness was defined as having one of a range of 
major psychiatric disorders such as schizophrenia spectrum disorders, bipolar and unipolar 
mood disorders (Ruggeri et al., 2000). Schizophrenia spectrum disorders refer to 
schizophreniform, schizophrenia and schizoaffective disorders. The disorder must persist 
over time and be associated with severe, persistent disability in social, work-related and other 
important areas of functioning (Schinnar et al., 1990). All participants were interviewed by a 
clinician who collated demographic and clinical data using a structured questionnaire. Axis I 
diagnoses were assessed using diagnostic statistical manual (DSM) IV TR criteria. 
Illicit substance and alcohol use 
We screened potential participants for the presence or absence of methamphetamine use by 
perusal of clinical case records and by obtaining additional information from treating 
clinicians. For eligible patients who agreed to participate we then further assessed drug and 
alcohol use utilizing two clinician administered scales: the alcohol use scale (AUS) and drug 
use scale (DUS) (Mueser et al., 1995).These are each 5-point scales based on DSM III-R 
criteria and assess substance use in the past 6 months. The scales have proven reliability, 
sensitivity and specificity in patients with serious mental illness (Mueser et al., 1995). 
Participants with a SMI and methamphetamine use had to score 2 or more on the DUS. The 
comparison group consisted of participants with a SMI who were free of methamphetamine 
use. 
HIV associated sexual risk behaviour 
We used the KAP-Q sexual risk assessment tool, a structured clinician administered 
questionnaire that assesses sexual behaviour during the past 6 months. The KAP-Q sexual 
risk assessment tool (Smit et al., 2006) was developed in the Cape Town HIV Consortium in 
collaboration with the Desmond Tutu HIV Fund. It has proven validity in patients with 
psychiatric disorders in the South African  population (Smit et al., 2006). In addition to the 
existing questions in this instrument we added a further 3 questions. These questions 
ascertain the presence of sexual behaviours after the use of substances including anal sex, 












We conducted a comparative analysis between methamphetamine users and non-
methamphetamine users for various items on the sexual risk questionnaire. We assessed the 
data for deviations from normality by means of the Shapiro-Wilk test for normality. Where 
appropriate, non-normal data was log-transformed (log10) prior to analysis. Categorical data 
was analysed using the Chi-square or Fisher’s exact test where appropriate. Normally 
distributed continuous data was analysed using the student’s t-test. Where log transformation 
did not normalise data, we used the Wilcoxon rank-sum test to analyse non-normally 
distributed data. Significance levels were set at 5% level and tests were two-sided throughout. 
All data was analysed using STATA version 11 for windows (StataCorp, 2009). 
Results 
Sample characteristics 
The sample consisted of 100 participants, 46 females and 54 males. Majority (N=70) of the
participants were between 18-39 years old and single (N=75), with 11 participants reporting 
previous marriage and 13 participants currently living with a partner. All participants had 
attended formal education with 88 participants attaining some level of secondary education.
Regarding ethnicity, 60% were of ‘coloured’ descent, 29% were black, 10% Caucasian and
1% Asian. The ethnic characteristics of the sample reflect the ethnic trends of the Western 
Cape Metro region where the sample was collected. The Western Cape population is 
characterised by 49% being ‘coloured’, 33% ‘black’, 16% Caucasian, 1% Asian (South 
African Population census, 2011). The terms ‘black’ and ‘coloured’ stem from the Apartheid 
era in South Africa. ‘Coloured’ refers to people of mixed European, black and/or Asian
ancestry (Wechsberg et al., 2008). The terms do not infer inherent characteristics and for the 
majority, the term ‘coloured’ is not considered offensive and preferred to ‘mixed race’
(Wechsberg et al., 2008).
Participants with a SMI and MA use comprised 40% (N=40) of the total sample. Table 1 
compares demographic characteristics between methamphetamine and non-
methamphetamine users. There were significant differences between MA and non-MA users 
in terms of age, gender, marital status, ethnic group and level of education. The majority of 
MA users were between 18-29 years old (N= 27; 67.5%), single (never married: N=36; 90%), 
male (N=27; 67.5%), of ‘coloured’ ethnicity (N=31; 77.5%) and had significantly fewer years 












Table 1.  Demographic characteristics of methamphetamine users and non-users 
Characteristic 
Methamphetamine use 




Age N % N %       
 18 – 29 27 67.5 15 25 χ2 = 22.15 3 < 0.001 
 30 – 39 9 22.5 19 31.7       
 40 – 49 4 10 11 18.3       
 50 – 59 0 0 15 25       
Gender                
 Male 27 67.5 27 45 χ2 = 4.89 1 0.027 
 Female 13 32.5 33 55       
Ethnicity  N % N %       
 Caucasian 2 5 8 13.3 Fishers exact test -  0.022 
 African 7 17.5 22 36.7       
 Coloured 31 77.5 29 48.3       
 Asian 0 0 1 1.67       
Marital status  N % N %       
 never married 36 90 39 66.1 χ2 = 7.43 2 0.024 
 past marriage 2 5 9 15.3       
 with partner 2 5 11 18.6       
Education Level        
(Number  of years ) 
              
Median / iqr 9 3 10 4 Wilcoxon rank-sum  - 0.017 
 
Clinical and substance using characteristics of sample 
Table 2 contains the diagnostic breakdown of MA compared to non-MA users. Although 
almost half (N=45) of the total sample received schizophrenia spectrum diagnoses, there were 
significant differences between the MA users and non-MA users with regards to the axis I 
psychiatric diagnosis. The majority of MA users (N=20; 50%) received a substance induced 
diagnosis whereas majority of non-MA users (N=33; 55%) received a schizophrenia 
spectrum diagnosis. Among the remaining MA users, a diagnosis of schizophrenia spectrum 
disorder (N=12; 30%) was more common compared to a diagnosis of bipolar mood disorder 
(N=5; 12.5%) whereas among the remaining non-methamphetamine users, a diagnosis of 
bipolar mood disorder (N=14; 23.3%) was more frequent compared to substance induced 
disorders (N=7; 11.7%). There were no significant differences between the MA users and 
non-MA users in terms of the occurrence of manic episodes in the past 6 months. 
Table 3 compares co-morbid substance using trends amongst methamphetamine and non-
methamphetamine users. Across both methamphetamine and non-methamphetamine users 
alcohol was the most frequently used co-morbid substance and was reported by just over half 
of the total sample (N= 54; 54%). However, methamphetamine users had significantly higher 
rates of co-morbid alcohol use (N=27; 67.5%) in comparison to non-methamphetamine users 
(N=27; 45%) (p=0.027). Co-morbid use of substances other than alcohol was also 
significantly higher among methamphetamine users (N=34; 85%) compared to non-
methamphetamine users (N=17; 28.3%) (p<0.001). Among users of other (non-
methamphetamine and non-alcohol substances) substances, cannabis was the most frequently 
used substance (N=51; 51%), followed by methaqualone (N=18; 32.3%), then cocaine (N=3; 
5.8%) and lastly ecstasy (N=2; 3.9%). Polysubstance use, defined as concurrent use of 2 or 
more substances, occurred significantly more frequently in methamphetamine users (N=34, 











Table 2: Comparison of Axis I diagnoses between methamphetamine and non-methamphetamine users 
Characteristic 
Methamphetamine use 




Diagnosis N % N % 
Schizophrenia spectrum1 12 30 33 55 χ2 = 18.04 3 < 0.001 
Bipolar mood disorder type 1 5 12.5 14 23.3 
Substance induced (SIPD/SIMD)2 20 50 7 11.7 
 Other3 3 7.5 6 10 
Mania in past 6 months N % N % 
Present 7 17.5 14 23.3 χ2 = 0.49 1 0.483 
1 Schizophrenia spectrum disorders include schizophreniform, schizophrenia and schizoaffective disorders 
2. SIPD: substance induced psychotic disorder, SIMD : substance induced mood disorder
3 Other diagnoses included: psychosis due to a general medical condition, major depressive disorder, psychosis not otherwise specified 
Table 3: Co-morbid substance use amongst methamphetamine and non-methamphetamine users 
Co-morbid Substance use 
Methamphetamine use 
OR 95% CI 
Test
statistic




Comorbid Alcohol N % N % 
  Present 27 67.5 27 45 2.54 1.02 - 6.40 χ2 = 4.89 0.027 
Absent 13 32.5 33 55 
Other Substance    use 1 
  Present 34 85 17 28.3 14.33 4.68 - 48.06 χ2 = 30.83 <0.001 
Absent 6 15 43 71.7 
1 Other substances include cannabis (51%), methaqualone (32.3%), cocaine (5.8%), and ecstasy (3.9%) 
Comparison of sexual risk behaviours between methamphetamine and non-
methamphetamine users 
Table 4 tabulates several high risk sexual behaviours which differed significantly between
methamphetamine and non-m thamphetamine users whilst table 5 depicts the sexual risk 
behaviours which did not differ significantly across methamphetamine and non-
methamphetamine users. Overall, the majority of the total sample were sexually active during 
the past 6 months prior to admission (N=71; 71%). The average age of sexual debut was 
significantly younger among methamphetamine users (mean age in years: 15.75) compared to 
non-methamphetamine users (mean age in years: 18.0) (p=0.003). Transactional sex was
significantly higher among methamphetamine users (N=13; 32.5%) compared to non-
methamphetamine users (N=4; 6.7%) (p<0.001). A significantly greater proportion of
methamphetamine users (N=19; 47.5%) reported sexual activity after using substances
compared to non-methamphetamine users (N=15; 25%) (p=0.02). In addition, significantly
greater proportion of methamphetamine users (N=19; 47.5%) reported sex with a stranger
compared to non-methamphetamine users (N=16; 26.7%) (p=0.032).
There were no statistically significant differences between methamphetamine versus non-
methamphetamine users when compared on other risk markers such as sexual activity in the 6 
months preceding admission, the number of sexual partners, condom use, knowledge of STD 











sexually transmitted disease in the past 6 months and engagement in oral, anal or multiple 
partners sex whilst intoxicated (see table 5).  
Table 4: Sexual risk characteristics which did differ between methamphetamine and non-methamphetamine users 
KAPQ Characteristics 
Methamphetamine use 




Age of first intercourse 
mean / sd 15.75 3.06 18 3.85 − 0.81 - 3.69 t = 3.09 97 0.003 
median / iqr 16 4 18 5 
Trans actional sex: past 6 months1   N     % N % 
Present 13 32.5 4 6.7 6.74  1.82 – 30.46    χ2 = 11.35 1 < 0.001 
Absent 27 67.5 56 93.3 
Sexual activity  after substance 
use: past 6 months 
     N   % 
N  % 
Present 19 47.5 15 25. 2.71 1.06 - 6.96    χ2 = 5.41 1 0.020 
Absent 21 52.5 45 75. 
Sex with a stranger: past 6 months2 N % N % 
Present 19 47.5 16 26.7 2.49 0.98 - 6.31 χ2 = 4.58 1 0.032 
Absent 21 52.5 44 73.3. 
1. Transactional sex: sex in exchange for money, drugs or shelter.
2. Sex with a stranger was defined as sexual intercourse with someone known for less than 24 hours
Table 5: Sexual risk behaviours which did not differ significantly between MA & non-MA users
KAPQ Characteristics 
Methamphetamine use 







Number of sexual partners 
mean / sd 6.9 5.1 5.5 5.4 − -0.22 - 0.15 t = -1.73 97 0.086 
median / iqr 5 7 4 5 
Knowledge:male condom1 N % N % 
Present 39 97.5 57 96.6 1.37 0.07 - 82.77 Fishers exact test − 0.799 
Absent 1 2.5 2 3.4 
Knowledge: female condom1 N % N % 
Present 30 75 33 55.9 2.36 0.91 - 6.40 χ2 = 3.75 1 0.053 
Absent 10 25 26 44.1 
Sexual activity: past 
6months 
N % N % 
Present 29 73% 42 70% 1.13 0.43 – 3.06 χ2 = 0.07 1 0.787 
Absent 11 27.5% 18 30% 
Pressured/forced into sex N % N % 
Present 12 30 14 23.3 1.41 0.51 - 3.81 χ2 =0.55 1 0.457 
Absent 28 70 46 76.7 
STD in past 6 months N % N % 
Present 11 27.5 10 16.7 1.89 0.64 - 5.63 χ2 =1.70 1 0.193 
Absent 29 72.5 50 83.3 
Oral sex whilst intoxicated N % N % 
Present 2 5 7 11.7 0.39 0.03 - 2.27 Fishers exact test − 0.309 
Absent 38 95 53 88.3 
Anal sex whilst intoxicated N % N % 
Present 1 2.5 3 5 0.48 0.01 - 6.36 Fishers exact test − 0.648 
Absent 39 97.5 57 95 
Multiple partners whilst 
intoxicated  
N % N % 
Present 2 5 2 3.3 1.52 0.10- 21.79 Fishers exact test − 1.000 
Absent 38 95 58 96.7 












Forty percent of a total of 100 participants used MA. In keeping with local and international 
findings, most MA users within our sample were young (18-39years), single and male (Corsi 
& Booth, 2008; Meade et al., 2012). As reflected by provincial population trends (South 
African Population census, 2011)  and local studies (Pluddemann et al., 2008), the majority 
(N=31) of MA users were of mixed ethnic ‘coloured’ background. MA users (N=34; 85%) 
were more likely than non–users (N=12; 20%) to report polysubstance use defined as 
concurrent use of 2 or more substances. Explanations thereof may include the need for 
‘downers’ to enable relief of unwanted effects of MA intoxication such as insomnia 
(Bramness et al., 2012). Alternatively, polysubstance use may be secondary to underlying 
personality traits of impulsivity and novelty seeking in the mentally ill person (Meade, 2006). 
Similar to previous studies by Simbayi et al. (Simbayi et al., 2006) alcohol use was more 
frequent amongst MA users (67.5%) than non-users (45%). 
Consistent with international findings, majority of our patient sample were sexually active
(Grassi, 1996). Similar to other studies; we also found that HASRB were higher among 
mentally ill patients using illicit substances (Cournos & McKinnon, 1997; Meade, 2006;
Meade et al., 2008), particularly among those using methamphetamine. Sexual risk
behaviours were rife across MA and non-MA using mentally ill patients, reflecting global 
concerns of unsafe sexual practices amongst seriously mentally ill patients (Counos, 
McKinnon, & Meyer-Bahlburg., 1993; Cournos & McKinnon, 1997; Grassi, 1996;
McDermott, Sautter, Winstead, & Quirk., 1994). This study illustrates the following HASRB
were more common among methamphetamine using mentally ill patients compared to non-
methamphetamine using patients: earlier age of sexual debut, transactional sex, sex with a 
stranger and sexual activity following substance use. Our findings of earlier age of sexual 
debut among methamphetamine users are similar to international findings among
methamphetamine users from the general population (Plüddemann, Myers, & Parry, 2008).
However it is difficult to make accurate comparisons across dissimilar study populations. 
Meade (Meade et al., 2006) and Randolph et al. (Randolph et al., 2007) elicited higher rates
of HASRB amongst mentally ill patients with substance use inclusive of but not exclusive to
amphetamine use. In a sample of female psychiatric patients Randolph et al. (Randolph et al.,
2007) reported higher rates of unprotected intercourse and intercourse with multiple partners 
among substance using patients compared to non-using patients. However, it was difficult to
compare our results with either Meade (Meade, 2006) or Randolph et al. (Randolph et al., 
2007) because neither had separated amphetamine use from other substance use and neither
reported specific HASRB associated with meth/amphetamine use. Hampton et al. (Hampton
et al., 2012) explored sexual risk behaviours among dual and triple diagnosed mentally ill 
patients. Dual diagnosis referred to mental illness with co-morbid substance use disorders 
including intravenous amphetamines whilst triple diagnosis referred to dual diagnosis and
HIV or Hepatitis C (Hampton et al., 2012). Similar to our findings, Hampton et al. described 
a strong association between amphetamine use and sex with a stranger (Hampton et al.,











Hampton et al. (Hampton et al., 2012) assessed only intravenous amphetamine use. No 
further associations between amphetamine use and other HIV associated sexual risk
behaviours were reported by Hampton et al. (Hampton et al., 2012). In our study, the high
prevalence of transactional sex amongst methamphetamine users (N=13; 32.5%) is
particularly concerning. Impoverishment among mentally ill patients may drive sex trade for
food or accommodation (Kawakami et al., 2012; Kessler et al., 2008) or patients may
exchange sex for more illicit substance (Shannon et al., 2008). We are unaware of studies
among patients with SMI, evidencing associations between meth/amphetamine use and
intercourse following substance use. Impaired social interactional skills or poor assertiveness
combined with sexual disinhibition following methamphetamine intoxication are possible
explanations for the high rate of sexual intercourse following substance use among 
methamphetamine users (N=19; 47.5%) in our sample. Anal intercourse was infrequently
reported and therefore varied significantly from reports of HASRB among other MA using
populations (Beyrer , 2007; CDC, 2007; Shoptaw & Reback, 2007).Under reporting of anal
intercourse may be secondary to stigmatization of homosexual behaviours in South Africa
(Dietrich et al., 2011). Overall, this study suggests that methamphetamine use increases the
risk of HASRB among people with SMI.
Strengths of this study include its large, ethnically diverse sample population and the
inclusion of non-MA, non-substance using mentally ill participants who served as a
comparison group to our MA using population. This study does have several limitations. 
Firstly the study was based on inpatients with SMI, making it difficult to generalise results to 
outpatient populations. Secondly, under-reporting of sexual behaviours by participants in an 
effort to avoid stigma (Dietrich et al., 2011) is possible. Thirdly, this study relied on self-
reporting of substance using behaviour in the absence of confirmatory laboratory toxicology
testing. Minimization of quantity/duration and types of substance use cannot be excluded. In
turn, non-specific behaviours such as impulsivity, novelty seeking, and self-destructive
behaviours among patients with SMI may act as confounders for HASRB. In addition, a large
proportion of MA (N=27; 45%) and non-MA users (N=27; 67.5%) (p=0.027) were using 
alcohol. Alcohol use by itself is associated with sexual risk behaviour such as infrequent
condom usage (Weinhardt et al., 2001) and transactional sex (Robertson & Plant, 1988) and
may therefore also influence the risk for HASRB. Methamphetamine users had high rates of
polysubstance use, where the effect of other substances may elevate risk of HASRB
(McKinnon K et al., 2001; Meade et al., 2005b; Meade et al., 2008; Rosenberg, Bleiberg,
Koscis, & Gross, 2003) and thereby potentially confound our results. After alcohol, cannabis 
was the most common concurrently used substance among our sample. There are equivocal
results for HASRB and its association with cannabis use (Devieux et al., 2007). This was an 
exploratory study which examined sexual risk behaviours among MA using mentally ill 
people compared to non-MA users with SMI. Hence our finding of increased sexual risk 
behaviours in methamphetamine users compared to non-methamphetamine users needs to be
interpreted with caution and can only be considered preliminary. Future research using 
multivariate statistical procedures examining the effects of MA use on HASRB in persons 











well as other potential covariates such as gender age and other demographic variables, is 
needed. 
Conclusion 
In conclusion, rates of particular HASRB such as transactional sex, younger age at sexual 
debut, sex with strangers and sex after drug intoxication are higher among methamphetamine 
using mentally ill patients as compared to non-users.  MA users may therefore constitute a 
particularly ‘high HIV risk group’. There is an urgent need for implementation of an HIV 
intervention programme designed to meet the needs of patients with SMI. Introduction of 
HIV/AIDS awareness programmes at all levels of mental health care delivery is an important 
first step. There is positive evidence for the use of small, intense, HIV risk reduction 
intervention groups (Berkman, Cerwonka, & Sohler, 2006) amongst mentally ill populations. 
We suggest continuous psycho-education around HASRB and regular HIV testing amongst 
this HIV vulnerable population. 
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Section A: Demographics 
First I’m going to ask you a few background questions. 
1. Sex (Code by observation)
2. What is your date of birth?
3. Which of the following best describes your race?
4. What is your marital status?
Date: Time: 
Patient code: Ward: 
Male  Female
dd/mm/yy Age 
10 – 20  :  
21 – 30    :   
31 – 40    :   
41 – 50    :   
51 – 60    :   
White/Caucasian Black Coloured 
Indian Asian Other 
Missing 
Married Separated Divorced 











5. How many children do you have?
6. How many of your children are under 18?
7. What is the highest grade in school you have completed?
8. Do you have a university degree or
diploma?
9. If Yes, what degree is that?
10. Do you have any other training? (SPECIFY HERE)
11. Have you been a student during the past year?
12. What level are you studying at?
Number of 
Chn: 
None  Refuse to answer              
Number of 
Chn.: 
None  Refuse to answer 
Yes  No  Refuse to answer       
Yes  No  Refuse to 
answer   
Secondary school High school Undergraduate 
Postgraduate Technikon Technical school 











Section B: Substance use    
Now I will ask you a few questions about substance use. 

































2. Regarding alcohol use:
Section C:  HIV status and physical health: 
1. Have you ever had an HIV test?  YES   /     NO 

























ADMISSION    
≤ 3 MONTHS AGO IF > 3 MONTHS AGO SPECIFY 











a. If YES, what was the result?   Positive  /Negative  / Unknown 
3. Regarding HIV status:
HIV status known by patient on 
current interview   
Yes No 
HIV status known by treating team 
on admission    
Yes No 
Present day HIV status  Positive Negative Unknown














Section D: HIV Risk behaviour scale: KAP- Q scale. 
This section will ask you some personal questions about your sexual experiences, condom-use and 
other issues that have been known to increase the risk of contracting the HIV virus. Some of these 
questions are very personal and may cause discomfort. You can refuse to answer any question you 
are not comfortable with but we would appreciate it if you try to answer all questions as honestly as 
possible. Remember that all answers are CONFIDENTIAL. 
Risk Behaviours 
Please note that the word sex refers to vaginal, anal and oral sex
1. At what age did you first have sex? Age in years __________
2. Who was the first person you had sex with?
  please choose only one 
 Husband / Steady partner 
 Friend
 Stranger – consensual (‘one-night stand’)
 Stranger – non-consensual (Rape)
 Other
 Refuse to answer
3. How many people have you had sex  with in
your life?
Number _______________ 
4. Do you know what a male condom is?  Yes   No   Unsure   Refuse to answer 
5. Do you know what a female condom is?  Yes   No   Unsure   Refuse to answer 
6. Have you EVER used a male or female condom
during sex?
 Yes   No   Refuse to answer 
7. Have you had sex in the last 6 months?  Yes   No   Refuse to answer 
8. Have you used a male or female condom during sex
in the last 6 months?
 Yes   No  Refuse to answer 

















         please only tick ONE or TWO that MOSTLY apply  to 
you 
 Friend   
 Other    
 Refuse to answer   
9. During the past 6 months, did you have sex in 
exchange for money, drugs or a place to stay?   
 
 Yes         No           Refuse to answer   
10. During the past 6 months have you had sex after 
heavily using alcohol, dagga (ganja) or other drugs?  
 
 Yes       No        Refuse to answer   
11. During the past 6 months have you had sex with a 
person you had known for less than one day?   
 
 Yes       No  Refuse to answer   
12.   Have you ever been raped or      pressured into 
unwanted sex?  
 
 Yes       No        Refuse to answer   
13. Have you ever heard of sexually transmitted diseases 
(or STDs) other than HIV that can be transmitted 
through sexual intercourse?   
 
 Yes        No        Refuse to answer   
14. During the past 6 months, have you had a sexually 
transmitted disease, where you had a genital 
discharge and/or sores/ulcers that needed 
treatment at the hospital or clinic?  
 
 Yes          No          Refuse to answer    
15. Have you ever been part of a traditional     practice, 
where a group of people shared the same 
knife/needle for cutting (circumcision or scarification 
for  example)?   
 
 Yes          No         Refuse to answer   
16. In the past year, have you been to any of the 
following health providers for any health 
problem? 
             
 
 Nurse / doctor at a hospital  
 Private doctor or GP  
 Chemist / Pharmacist  
 Traditional healer  
 Healing church  
 Other  
 I was not sick during the last year  
 Refuse to answer  
17. Do you know if the person or people you are 
currently having sex with are HIV positive?  
 Yes, one of them is definitely HIV positive      
 No, all of them were tested and are HIV negative     
 Unsure, some of them may be HIV positive but I cannot say 
for sure     











        17a) If YES, do you use a condom during sex?  All of the time      
 Most of the time  
 Some of the time 
 Never       
 Refuse to answer 
18. Do you think that any of the people you are
currently having sex with may be at risk for
becoming HIV positive?
 Yes   No   Unsure   Refuse to   answer 
19. Do you think you may be at risk for becoming HIV
positive?
 Yes   No   Unsure   Refuse to answer 
20. Do you think someone else, such as a friend for
example, who has the same lifestyle that you have
may be at risk of becoming infected with HIV?  Yes   No  Unsure Refuse to answer 
Sexual Risk Questionnaire, prepared by Joalida Smit and Keren Middelkoop of the Cape Town HIV Consortium
Translated: July 2003
In addition to KAPQ questions, ask the following question:
Have you, while intoxicated, engaged in any of the following sexual behaviours that you otherwise (i.e. had not 
been intoxicated) would not have participated in?
Section E: Clinical data. 
1. Age of onset of illness( in years) :
Oral intercourse  YES   NO   UNSURE     NO ANSWER 
Anal intercourse  YES   NO   UNSURE     NO ANSWER 
Multiple partners  YES   NO   UNSURE     NO ANSWER 
Other YES   NO   UNSURE     NO ANSWER 











2. Principle Axis I diagnosis according to DSM-IV (Working/clinical team diagnosis)
DSM-IV diagnosis: Comments/subtype/specs X 
Schizophrenia 
Schizophreniform disorder 
Bipolar type I mood disorder 
Schizoaffective disorder 
Brief psychotic disorder 
Delusional disorder 
Major depressive disorder 
Psychotic disorder due to GMC 
Substance induced psychotic 
disorder   
Substance induced mood disorder 
Other: Specify  
3. Number of previous hospital admissions for mental illness: 
4. Have you had any hospital admissions prior to the current admission in past 6 months?
YES NO 
5. Is the patient, based on clinical judgment & treating team, currently manic?
 













7. Is impulsivity reported by patient?
YES NO 
8. Is impulsivity observed during this interview?
YES NO 
9. Is patient currently psychotic (but able to consent)?
YES NO 
10. Have you had any previous episodes of psychosis prior to the current admission during the past 6 months?
YES NO 
11. Is the patient, based on clinical judgment/ treating team, currently depressed?
YES NO 
12. Is cognitive slowing observed during the interview?
YES NO
13. Is there evidence of an Axis II diagnosis OR Axis II Traits?
On History 
   YES   NO  
On record in clinical notes 
    YES   NO 
On clinical suspicion during 
interview 
    YES   NO 












Clinician administered Alcohol Use Scale
FORM C.2





This scale pertains to your client's use of alcohol over the past 6 months. Rate the worst period of alcohol
use during this interval. If the client is in an institution, the reporting interval is the time period prior to
institutionalization. Complete the information-gathering portion of this form, and then rate your client on
the 5-point Rating Scale at the end of this form.
Use
Inquire whether the client has used alcohol over the past 6 months.
No
Yes
If no, give the client a 1 on the Rating Scale and complete the "Sources of Information" section at the end
of this form. If yes, complete the rest of the form.
Abuse
Consequences of use in past 6 months. Check all recurrent problems related to the alcohol use that have
persisted for at least 1 month. Use client report, plus any other sources of information (i.e., urine screens,
collateral reports).
Social functioning and legal status
Family problems
Housing instability






From Integrated Treatment for Dual Disorders by Kim T. Mueser, Douglas L. Noordsy, Robert E. Drake, and Lindy Fox. 
Copyright 2003 by The 
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FORM C.2. Alcohol Use Scale—Revised (page 2 of 4) 
Role functioning 
Employment difficulties (e.g., loss of job, accidents on the job) 
Difficulty attending or keeping up in school 
Parenting difficulties (e.g., failure to care for children) 
Physical status 
Hygiene problems 








Sudden mood shifts 
Appearance of new symptoms 
Use in dangerous situations 
When driving 
When operating machinery 
If no problems are noted for abuse, stop here and rate client a 2 on the Rating Scale. If problems are 
noted, check for dependence (below). 
Dependence 
The client needs to have at least one symptom present in three out of the following seven categories to 
meet criteria for dependence. If not, rate the client a 3 on the Rating Scale for abuse. 
1. Greater amounts or intervals of use than intended 
Drinking more than planned 
Drinking longer than planned 
Repeated unsuccessful attempts to cut down 
2. Frequent intoxication, or withdrawal, interferes with other activities 














FORM C.2. Alcohol Use Scale—Revised (page 3 of 4) 
3. Important activities given up because of alcohol use
Drinking instead of working 
Drinking instead of spending time on leisure activities 
Drinking instead of spending time with family or friends 
4. Continued use despite knowledge of alcohol-related problems
Drinking is causing problems, but client continues to drink 
5. Marked tolerance
Needing to drink a lot more to get high 
Diminished effect with use of same amount of alcohol 





Feeling nauseated or vomiting 
Feeling agitated 
Feeling anxious 
7. Alcohol taken to relieve or avoid withdrawal symptoms
Drinking to keep from getting sick from withdrawal symptoms 
Drinking to stop the shakes or other withdrawal symptoms 
If the client meets the criteria for dependence, move on to see whether the client has severe dependence, 
where problems are so severe that living in the community is difficult. 
DEPENDENCE WITH INSTITUTIONALIZATION 
Psychiatric hospitalization(s) 
Inpatient treatment(s) for substance abuse 
Incarceration(s) 
If the client has had more than one psychiatric hospitalization, inpatient treatment for substance abuse, or 
incarceration, or if the client has spent 3 or more months of the past 6 institutionalized, rate the client a 5 
on the Rating Scale. If none of these apply, rate the client a 4. 
(continued) 
All 












Based on the information summarized on the previous pages, rate your client's use of alcohol during the
worst period over the past 6 months, according to the following scale.
1 = Abstinence. Client has not used alcohol over the past 6 months.
2 = Use without impairment. Client has used alcohol over the past 6 months, but there is no
evidence of persistent or recurrent problems in social functioning, legal status, role functioning,
psychiatric status, or physical problems related to use, and no evidence of recurrent dangerous
use.
3 = Abuse. Client has used alcohol over the past 6 months, and there is evidence of persistent
or recurrent problems in social functioning, legal status, role functioning, psychiatric status, or
physical problems related to use, or evidence of recurrent dangerous use. For example,
recurrent alcohol use leads to disruptive behavior and housing problems. Problems have
persisted for at least 1 month.
4 = Dependence. Client meets criteria for abuse, plus at least three of the following: greater
amounts of use than intended; much of time spent obtaining or using alcohol; frequent
intoxication or withdrawal interferes with other activities; important activities given up because
of alcohol use; continued use despite knowledge of alcohol-related problems; marked
tolerance; characteristic withdrawal symptoms; or alcohol taken to relieve or avoid withdrawal
symptoms. For example, drinking binges and preoccupation with drinking have caused client to
drop out of job training and non-drinking-related social activities.
5 = Dependence with institutionalization. Client meets criteria for dependence, plus related
problems are so severe that they make noninstitutional living difficult. For example, constant






































Clinician administered Drug Use Scale 
 
FORM C.3 





This scale pertains to your client's drug use over the past 6 months. Rate the worst period of drug use during 
this interval. If the client is in an institution, the reporting interval is the time period prior to 
institutionalization. Complete the information-gathering portion of this form, and then rate your client on 
the 5-point Rating Scale at the end of this form. 
Use 
Inquire whether the client has used drugs (other than as prescribed) over the past 6 months. 
No 
Yes 
If no, give the client a 1 on the Rating Scale and complete the "Sources of Information" section at the end 
of this form. If yes, complete the rest of the form. 









See last page of form for specific drugs within each category and slang words. 
(continued) 
From Integrated Treatment for Dual Disorders by Kim T. Mueser, Douglas L. Noordsy, Robert E. Drake, and Lindy Fox. 
Copyright 2003 by The 
Guilford Press. Permission to photocopy this form is granted to purchasers of this book for personal use only (see copyright 
page for details). 
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Consequences of use in past 6 months. Check all recurrent problems related to the drug use that have
persisted for at least 1 month. Use client report, plus any other sources of information (i.e., urine screens,
collateral reports).
Social functioning and legal status
Family problems
Housing instability






Employment difficulties (e.g., loss of job, accidents on the job)
Difficulty attending or keeping up in school
Parenting difficulties (e.g., failure to care for children)
Physical status
Hygiene problems













problems are noted for abuse, stop here and rate client a 2 on the Rating Scale. If problems are














FORM C.3. Drug Use Scale—Revised (page 3 of 6) 
Dependence 
The client needs to have at least one symptom present in three out of the seven categories to meet criteria 
for dependence. If not, rate the client a 3 on the Rating Scale for abuse. 
1. Greater amounts or intervals of drug use than intended 
Using more drugs than planned 
Using drugs longer than planned 
Repeated unsuccessful attempts to cut down use of drugs 
2. Frequent drug use or withdrawal interferes with other activities 
Spending most of the time using drugs 
Lengthy time spent recovering from effects 
3. Important activities given up because of drug use 
Using drugs instead of working 
Using drugs instead of spending time on leisure activities 
Using drugs instead of spending time with family or friends 
4. Continued use despite knowledge of drug-related problems 
Drug use is causing problems, but client continues to use 
5. Marked tolerance 
Needing to use a lot more drugs to achieve desired effect 
Diminished effect with use of same amount of drug 
6. Characteristic withdrawal symptoms 
Sedatives/hypnotics/anxiolytics 
Sweating or increased pulse rate 
Increased hand tremor 
Insomnia 
Nausea or vomiting 
Transient visual, tactile, or auditory hallucinations or illusions 
Anxiety 















Insomnia or hypersomnia 
Increased appetite 
Psychomotor retardation or agitation 
(continued) 
Alb 
FORM C.3. Drug Use Scale—Revised (page 4 of 6) 
Opiates 
Dysphoric mood 







7. Drug taken to relieve or avoid withdrawal symptoms
Use to keep from getting sick from withdrawal symptoms
Use when feeling sick with withdrawal symptoms
If the client meets the criteria for dependence, move on to see if the client has severe dependence, where
problems are so severe that living in the community is difficult.
Dependence with Institutionalization
Psychiatric hospitalization(s)
Inpatient treatment(s) for substance abuse
Incarceration(s)
If the client has had more than one psychiatric hospitalization, inpatient treatment for substance abuse, or
incarceration, or if the client has spent 3 or more months of the past 6 institutionalized, rate the client a 5
on the Rating Scale. If none of these apply, rate the client a 4.
Rating Scale
Based on the information summarized on the previous pages, rate your client's use of drugs during the
worst period over the past 6 months according to the following scale.
1 = Abstinence. Client has not used drugs over the past 6 months.
2 = Use without impairment. Client has used drugs over the past 6 months, but there is no
evidence of persistent or recurrent problems in social functioning, legal status, role functioning,












3 = Abuse. Client has used drugs over the past 6 months, and there is evidence of persistent
or recurrent problems in social functioning, legal status, role functioning, psychiatric status, or
physical status related to use, or evidence of recurrent dangerous use. For example, recurrent




FORM C.3. Drug Use Scale—Revised (page 5 of 6)
4 = Dependence. Client meets criteria for abuse, plus at least three of the following: greater
amounts of use than intended; much of time spent obtaining or using drugs; frequent
intoxication or withdrawal interferes with other activities; important activities given up because
of drug use; continued use despite knowledge of substance-related problems; marked
tolerance; characteristic withdrawal symptoms; or drugs taken to relieve or avoid withdrawal
symptoms. For example, binges and preoccupation with drugs have caused client to drop out
of job training and non-drug-related social activities.
5 = Dependence with institutionalization. Client meets criteria for dependence, plus related
problems are so severe that they make noninstitutional living difficult. For example, constant




























FORM C.3. Drug Use Scale—Revised (page 6 of 6)
DRUG NAMES AND SLANG WORDS
Sedatives/hypnotics/anxiolytics:
"Downers," Quaalude ("ludes"), Seconal ("reds"), Valium, Xanax, Librium, barbiturates ("barbs"),
Miltown, Ativan, Dalmane, Halcion, Restoril, Klonopin, "Special K," "roofies," "tranks."
Cannabis:
Marijuana ("pot," "grass," "weed," "reefer," "smoke," "dope," "joint," "ganga," "doobie," "wacky
tobacky," "Mary Jane"), hashish ("hash"), THC.
Stimulants:
"Uppers," amphetamine, "speed," "crystal meth," Dexedrine, Ritalin, "ice," "crank," "black beauties,"
"crosses," "hearts," STP, Ecstasy ("XTC," "X-file"), MDMA, MOA, DOM, DOB.
Opiates:
Heroin ("smack," "horse," "H"), morphine, opium (laudanum, paregoric, "Dover's powder"), methadone,
Darvon, codeine, Percodan, Demerol, Dilaudid.
Cocaine:
"coke," "crack," "speedball," "freebase," "rock," "snow," "8-ball," "flake"
Hallucinogens ("psychedelics"):
LSD ("acid," "windowpane," "blotter," "microdot"), mescaline (peyote, "buttons," "cactus," "mesc"),
psilocybin (mushrooms, "shrooms," "purple passion").
Over-the-counter:
Sleeping pills, diet pills, antihistamines.
Other:
PCP ("angel dust," "boat," "hog," "love boat"), steroids, "glue," ethyl chloride, paint, inhalants, nitrous
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